Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ENvue Medical (FEED) Consolidated Net Income (2017 - 2025)

Historic Consolidated Net Income for ENvue Medical (FEED) over the last 11 years, with Q3 2025 value amounting to $510000.0.

  • ENvue Medical's Consolidated Net Income rose 15110.22% to $510000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $74000.0, marking a year-over-year decrease of 9831.05%. This contributed to the annual value of $3.8 million for FY2024, which is 0.0% changed from last year.
  • Per ENvue Medical's latest filing, its Consolidated Net Income stood at $510000.0 for Q3 2025, which was up 15110.22% from -$4.0 million recorded in Q2 2025.
  • In the past 5 years, ENvue Medical's Consolidated Net Income ranged from a high of $5.6 billion in Q4 2022 and a low of -$6.7 million during Q3 2021
  • Over the past 5 years, ENvue Medical's median Consolidated Net Income value was -$955000.0 (recorded in 2022), while the average stood at $293.3 million.
  • In the last 5 years, ENvue Medical's Consolidated Net Income plummeted by 62396.96% in 2021 and then skyrocketed by 2119669.46% in 2022.
  • ENvue Medical's Consolidated Net Income (Quarter) stood at $26.1 million in 2021, then soared by 21196.69% to $5.6 billion in 2022, then plummeted by 99.88% to $6.7 million in 2023, then decreased by 9.38% to $6.0 million in 2024, then crashed by 91.54% to $510000.0 in 2025.
  • Its last three reported values are $510000.0 in Q3 2025, -$4.0 million for Q2 2025, and -$2.5 million during Q1 2025.